Home

Horizon Technology Finance Corporation - Common Stock (HRZN)

9.4550
+0.0250 (0.27%)

Horizon Technology Finance is a business development company that focuses on providing debt and equity financing to technology, life sciences, and other innovative companies

The firm specializes in lending to growth-stage companies and offers a range of financial solutions, including secured loans and equity investments, designed to support businesses in their expansion and operational needs. By partnering with these emerging firms, Horizon aims to foster innovation and growth in the technology sector while generating attractive returns for its investors.

SummaryNewsPress ReleasesChartHistoricalFAQ
Horizon Technology Finance Provides Fourth Quarter 2024 Portfolio Update
Horizon Technology Finance Corporation (NASDAQHRZN) (“HRZN” or “Horizon”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the fourth quarter ended December 31, 2024 and an update on the lending platform (“Horizon Platform”) of Horizon Technology Finance Management LLC (“HTFM”), its investment adviser.
Horizon Technology Finance Provides $35 Million Venture Loan Facility to Onkos Surgical® to Accelerate Commercialization of Novel Antibacterial Implant Technology
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon” or the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced it has provided a $35 million venture loan facility to Onkos Surgical (“Onkos”), of which $30 million has been initially funded.
Horizon Technology Finance Provides $10 Million Venture Loan Facility to Finexio
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon” or the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced it has provided a $10 million venture loan facility to OneNetwork, Inc. dba Finexio, of which $5 million has been initially funded.
Horizon Technology Finance Provides $10 Million Venture Loan Facility to Ursa Space Systems
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon” or the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced it has provided a $10 million venture loan facility to Ursa Space Systems Inc. (“Ursa Space”).
Horizon Technology Finance Announces Monthly Distributions for January, February and March 2025 Totaling $0.33 per Share
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that its board of directors has declared monthly cash distributions of $0.11 per share, payable in each of January, February and March 2025. The following tables show these distributions, payable as set forth in the tables below, total $0.33 per share. Since its 2010 initial public offering, Horizon has paid a total of $286 million in distributions to its shareholders.
Horizon Technology Finance Announces Third Quarter 2024 Financial Results
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon” or the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the third quarter ended September 30, 2024.
Horizon Technology Finance to Announce Third Quarter 2024 Financial Results
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the third quarter ended September 30, 2024 on Tuesday, October 29, 2024, after the close of market trading.
Horizon Technology Finance Provides Third Quarter 2024 Portfolio Update
Horizon Technology Finance Corporation (NASDAQHRZN) (“HRZN” or “Horizon”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the third quarter ended September 30, 2024 and an update on the lending platform (“Horizon Platform”) of Horizon Technology Finance Management LLC (“HTFM”), its investment adviser.
Horizon Technology Finance Provides $35 Million Venture Loan Facility to GT Medical Technologies
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon” or the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced it has provided a $35 million venture loan facility to GT Medical Technologies, Inc. (“GT MedTech”), of which $15 million has been initially funded.
Horizon Technology Finance Provides $35 Million Venture Loan Facility to Vesta Healthcare
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon” or the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced that on July 30, 2024 it provided a $35 million venture loan facility to Vesta Healthcare (aka Hometeam Technologies, Inc.), of which $25 million has been initially funded.
Horizon Technology Finance Management Announces Executive Promotions
Horizon Technology Finance Management LLC ("Horizon" or the “Company”), the manager and investment adviser for Horizon Technology Finance Corporation (NASDAQHRZN), a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, and an affiliate of Monroe Capital, announced today four senior members of its origination team have been promoted to new or expanded roles. These new positions will enhance the Company’s origination capabilities and portfolio management to better serve the needs of its existing and potential borrowers and their venture investors.
Horizon Technology Finance Announces Monthly Distributions for October, November and December 2024 Totaling $0.33 per Share
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that its board of directors has declared monthly cash distributions of $0.11 per share, payable in each of October, November and December 2024. The following tables show these distributions, payable as set forth in the tables below, total $0.33 per share. Since its 2010 initial public offering, Horizon has paid a total of $274 million in distributions to its shareholders.
Horizon Technology Finance Announces Second Quarter 2024 Financial Results
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon” or the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the second quarter ended June 30, 2024.
Horizon Technology Finance to Announce Second Quarter 2024 Financial Results
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the second quarter ended June 30, 2024 on Tuesday, July 30, 2024, after the close of market trading.
Horizon Technology Finance Provides Second Quarter 2024 Portfolio Update
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the second quarter ended June 30, 2024 and an update on the lending platform (“Horizon Platform”) of Horizon Technology Finance Management LLC (“HTFM”), its investment adviser.
Horizon Technology Finance Enhances Capital Resources and Increases Capacity via New $100 Million Credit Facility
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon” or the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced that Horizon Funding II, LLC, Horizon’s wholly-owned subsidiary (“HFII”), has closed a $100 million senior secured credit facility led by a large U.S. based insurance company pursuant to which HFII may issue up to $100 million of secured notes. The capacity under the credit facility may be increased to $200 million with the mutual agreement of Horizon and the lenders.
Horizon Technology Finance Announces Monthly Distributions for July, August and September 2024 Totaling $0.33 per Share
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that its board of directors has declared monthly cash distributions of $0.11 per share, payable in each of July, August and September 2024. The following tables show these distributions, payable as set forth in the tables below, total $0.33 per share. Since its 2010 initial public offering, Horizon has paid a total of $263 million in distributions to its shareholders.
Horizon Technology Finance Announces First Quarter 2024 Financial Results
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon” or the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the first quarter ended March 31, 2024.
Horizon Technology Finance to Announce First Quarter 2024 Financial Results
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the first quarter ended March 31, 2024 on Tuesday, April 30, 2024, after the close of market trading.
Horizon Technology Finance Provides First Quarter 2024 Portfolio Update
Horizon Technology Finance Corporation (NASDAQHRZN) (“Horizon”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the first quarter ended March 31, 2024 and an update on the lending platform (“Horizon Platform”) of Horizon Technology Finance Management LLC (“HTFM”), its investment adviser.
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation
WAYNE, Pa. and ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- In a major achievement, Avalo Therapeutics (Nasdaq: AVTX) proudly announces the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance Corporation (Nasdaq: HRZN). This significant milestone not only signifies the company's steadfast commitment to financial stability but also paves the way for future accelerated growth and progress toward executing its ambitious plans to advance its most promising drug candidates, including its anti-LIGHT mAb (quisovalimab or AVTX-002) and its BTLA agonist fusion protein (AVTX-008).
By Avalo Therapeutics · Via GlobeNewswire · September 26, 2023
HORIZON TECHNOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Horizon Technology Finance Corporation - HRZN
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Horizon Technology Finance Management LLC ("HTFM"), the investment adviser to Horizon Technology Finance Corporation (the “Company”) (NasdaqGS: HRZN) to an affiliate of Monroe Capital LLC. KSF is seeking to determine whether the transaction and the process that led to it are adequate and fair to the Company’s shareholders.
By Kahn Swick & Foti, LLC · Via Business Wire · February 28, 2023
Want Monthly Income? Here's 3 Dividend Stocks That Pay Monthly
Dividend stocks come in all shapes and sizes. They all share the objective of providing income to their investors. Dividend stocks can provide
Via MarketBeat · February 28, 2023
HRZN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Horizon Technology Finance Management LLC Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Horizon Technology Finance Corporation’s (NASDAQHRZN) investment adviser, Horizon Technology Finance Management LLC (“HTFM”), to an affiliate of Monroe Capital LLC is fair to Horizon shareholders.
By Halper Sadeh LLC · Via Business Wire · February 23, 2023
Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt
CAMBRIDGE, Mass., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, today announced it has entered into a senior secured loan agreement with Horizon Technology Finance Corporation (Horizon) (Nasdaq: HRZN), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services and sustainability industries. The $45 million term loan, which provides for three years of interest-only payments followed by a two-year amortization period, replaces the Company’s existing senior secured debt which would have begun amortizing in March 2023.
By Evelo Biosciences, Inc. · Via GlobeNewswire · December 16, 2022